Key Record Dates
ClinicalTrials.gov Identifier: | NCT04363216 |
---|---|
Brief Title: | Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment |
First Submitted : | April 23, 2020 |
First Submitted that Met QC Criteria : | April 23, 2020 |
First Posted : | April 27, 2020 |
Last Update Submitted that Met QC Criteria : | May 4, 2020 |
Last Update Posted : | May 5, 2020 |